Richard Lipkin is a Managing Director of Easton. Previously, he was a partner of Commerce Health Ventures, a life sciences healthcare fund, and Laird & Co., a private merchant bank; a biotech analyst consultant for a Goldman Sachs hedge fund and for DARPA; Executive Director of the Strang Cancer Prevention Center; and a prolific author, awarded the American Chemical Society’s Grady-Stack Award for research analysis. He studied theoretical neuroscience at Columbia University, and serves on many boards, councils, and committees for the Weizmann Institute of Science, Rockefeller and Columbia Universities, MBL, NYAS, and Montefiore Medical Center.
He is an honors graduate of Princeton University, has an MBA from Columbia, and is a Senior Staff Associate in Columbia’s Dept. of Neuroscience.